Elsevier is taking a hard-line posture against several different universities, asking them to take down scholarly research.
The Heath, Labor and Welfare ministry says a publisher passed off advertorials as articles.
Doctors shared their information preferences with CMI/Compas, revealing ways marketers can better pace their communications to max out channels.
Studies show that printed pieces still hold sway in the industry.
Starting next year, the BMJ will not publish academic papers on drugs or devices unless the relevant anonymized patient-level data are made available for third-party study.
The American Medical Association has wooed New England Journal of Medicine publisher Tom Easley to Chicago, where he will preside over the society's publications, soon to be rolled up into the JAMA brand.
A study found fraud rampant in retracted journal articles -- and publishers less than transparent about why articles were pulled
Privately owned Quadrant HealthCom acquired International Medical News Group (IMNG) from Elsevier, creating a new medical-publishing juggernaut.
Statistics show medical professionals are migrating toward iPads. Now, one medical journal publisher says, advertisers have followed.
In an effort to shore up their reputations, pharma and professional publishers have come together to craft an accountability plan.
Journals are a curious media form in that they provide fodder for debate on medical topics, but not a forum in which to hold one. Enter JAMA's new Viewpoint feature.
An email from Harvard University's Faculty Advisory Council over the cost of professional journals has touched off the latest round in the Universities vs Publishers sparring match.
Medical journal coverage of the question of physician-industry relationships is "unbalanced" and may be skewing public policy towards ever-more restrictive safeguards against industry influence.
Publicis Groupe is expanding its footprint in China, having acquired the healthcare communications agency U-Link Solutions Co. Ltd.
The Medical Advertising Hall of Fame announced its 2012 inductees: Medical Economics' Charles Daly, Sudler & Hennessey creative great Ernest Smith and LLNS co-founder Al Nickel.
Researchers analyzing the prevalence of ghostwriting in leading medical journals over more than a decade saw a decline but found inappropriate authorship remained all too common.
Four out of five ads analyzed in a study of physician-directed pharmaceutical advertising would definitely not pass FDA muster, or might have trouble doing so, said researchers. Their findings may have implications for the FDA, DDMAC and the "Bad Ad" program.
The American Association for Cancer Research will launch a new journal -- Cancer Discovery -- in April 2011. The peer-reviewed journal will focus on research spanning cancer science and medicine, including news, commentaries, and "Research Watch" summaries of important journal articles.
Quadrant HealthCom united two titles - The Female Patient and OBG Management - under an alliance providing advertisers with a "ping-pong" opportunity for campaigns.
Custom media provider Sequence Personal, and CMI, have partnered to create SequenceDoc, a portal for physicians offering tailored medical content served up as an on-demand print journal, or as a digital download.
Thieme Publishers will distribute UK-based Manson Publishing titles in the Americas and India, a portfolio that includes close to 100 medical and veterinary titles.
The New England Journal of Medicine launched a new website on July 24, including an archive of past issues dating back to 1812. Over 150,000 articles are now available for digital searching and perusal.
Sage, an international publisher of medical journals, books and electronic media, is shifting all of its 560-plus titles onto a new platform hosted by Stanford University Libraries' HighWire Press.
Medical society journals must ban ghostwritten articles and cannot place ads for drugs next to editorial content discussing those products or their makers under a sweeping ethics code signed by several major medical societies.
First Lady Michelle Obama's recent announcement of a campaign to end childhood obesity was not lost on medical publisher Mary Ann Liebert, Inc., which will roll out a new journal, Childhood Obesity, in June 2010.
An alliance with the nation's largest soft drink maker to sponsor advice on sugar-free alternatives has spurred criticism of the American Academy of Family Physicians (AAFP).
Researchers submitting manuscripts to many medical journals will have to fill out a more probing disclosure form aimed at exposing potential conflicts of interest.
JMI Health is launching PharmQD, which aims to be something like a cross between LinkedIn and Facebook for pharmacy students, hospital and retail pharmacists, said JMI SVP, eproducts Tina Pang Mayer (pictured).
If you still haven't entered the MM&M Awards 2009, then you'd better move fast--today (June 5) is the final deadline for submissions.
A pair of American Medical Association committee reports urges that industry-funded CME be put on a tighter leash, but they're a far cry from the ban on commercial support called for by the AMA's Council on Ethical and Judicial Affairs a year ago.
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.